Filtered By:
Specialty: Cardiology
Procedure: Electrocardiogram
This page shows you your search results in order of date. This is page number 13.
Order by Relevance | Date
Total 548 results found since Jan 2013.
Electrocardiographic abnormalities, preclinical carotid atherosclerosis andcardiovascular risk, in an apparently healthy real-world population: data from the project "No Stroke, No Infarction" of the rotary international - District 2110 "Sicily & amp; Malta"
CONCLUSIONS: A total of 302 (16.2%) subjects were at least at high risk for CV events according to the EUROSCORE, increasing to 681 (36,61% - p < 0.001) adding ACP. The combination of EUROSCORE with ECG may help to stratify CV risk in primary prevention. Carotid ultrasound furtherly increases the power of stratification of asymptomatic patients suitable for pharmacological treatment.PMID:34282855 | DOI:10.23736/S0392-9590.21.04637-X
Source: International Angiology - July 20, 2021 Category: Cardiology Authors: Salvatore Novo Davide Diana Claudio Tomasino Giulia Zambelli Antonino Mignano Andrea Scalmato Laura Maniscalco Alfredo Galassi Domenica Matranga Giuseppina Novo Source Type: research
EP News Clinical July 2021
Bernstein and colleagues (JAMA 2021; 325:2169-2177. PMID: 34061145) evaluated whether long term monitoring with an implantable cardiac monitor (ICM) is more effective than usual care for AF detection in patients with stroke from large- or small-vessel disease. Overall, 242 patients were randomized to ICM insertion within 10 days of the index stroke. Patients in the control group (n = 250) received site-specific usual care with external cardiac monitoring, such as 12-lead electrocardiograms, Holter monitoring, telemetry, or event recorders.
Source: Heart Rhythm - July 7, 2021 Category: Cardiology Authors: N. A. Mark Estes Source Type: research
EP News: Clinical
Bernstein et al (JAMA 2021;325:2169–2177; PMID: 34061145) evaluated whether long-term monitoring with an implantable cardiac monitor (ICM) is more effective than usual care for atrial fibrillation (AF) detection in patients with stroke from large- or small-vessel disease. Overall, 242 patients were randomize d to ICM insertion within 10 days of the index stroke. Patients in the control group (n = 250) received site-specific usual care with external cardiac monitoring, such as 12-lead electrocardiograms, Holter monitoring, telemetry, or event recorders.
Source: Heart Rhythm - July 7, 2021 Category: Cardiology Authors: N.A. Mark Estes Tags: EP News Source Type: research
Vericiguat in Patients with Atrial Fibrillation and Heart Failure with Reduced Ejection Fraction: Insights from the VICTORIA trial
ConclusionsAF was present in nearly half of this high-risk population with worsening HF. A history of AF alone at baseline portends an increased risk of cardiovascular death. Neither type of AF affected the beneficial effect of vericiguat. Development of AF post-randomization was associated with an increase in both cardiovascular death and HF hospitalization which was not influenced by vericiguat.This article is protected by copyright. All rights reserved.
Source: European Journal of Heart Failure - June 30, 2021 Category: Cardiology Authors: Piotr Ponikowski,
Wendimagegn Alemayehu,
Ali Oto,
M. Cecilia Bahit,
Ebrahim Noori,
Mahesh J. Patel,
Javed Butler,
Justin A. Ezekowitz,
Adrian F. Hernandez,
Carolyn S.P. Lam,
Christopher M. O'Connor,
Burkert Pieske,
Lothar Roessig,
Adriaan A. Tags: Research Article Source Type: research
Temporal changes of cardiac acoustic biomarkers and cardiac function in acute decompensated heart failure
ConclusionsSome CABs in ADHF patients changed significantly in the normal direction throughout the treatment course and could be useful biomarkers in ADHF management.
Source: ESC Heart Failure - June 29, 2021 Category: Cardiology Authors: Jun Shitara,
Takatoshi Kasai,
Nobutaka Murata,
Nobuhide Yamakawa,
Shoichiro Yatsu,
Azusa Murata,
Hiroki Matsumoto,
Takao Kato,
Shoko Suda,
Yuya Matsue,
Ryo Naito,
Masaru Hiki,
Hiroyuki Daida Tags: Original Research Article Source Type: research
Functional Calsequestrin-1 Is Expressed in the Heart and Its Deficiency Is Causally Related to Malignant Hyperthermia-Like Arrhythmia
Conclusions: Casq1 is expressed in the heart, where it regulates SR Ca2+ release and heart rate. Casq1 deficiency independently causes MH/EHS-like ventricular arrhythmia by trigger-induced Casq1 oligomerization and a relief of its inhibitory effect on RyR2-mediated Ca2+ release, thus revealing a new inherited arrhythmia and a novel mechanism for MH/EHS arrhythmogenesis.PMID:34162222 | DOI:10.1161/CIRCULATIONAHA.121.053255
Source: Circulation - June 24, 2021 Category: Cardiology Authors: Zhipeng Sun Luqi Wang Lu Han Yue Wang Yuan Zhou Qiang Li Yongquan Wu Shaletanati Talabieke Yunlong Hou Lulin Wu Ronghua Liu Zhiping Fu Hongjie You Bai-Yan Li Yuanyuan Zheng Dali Luo Source Type: research
Evaluation of the Feasibility and Efficacy of a Novel Device for Screening Silent Atrial Fibrillation (MYBEAT Trial)
CONCLUSIONS: The novel patch device using an original algorithm was beneficial for screening of silent AF.PMID:34148927 | DOI:10.1253/circj.CJ-20-1061
Source: Circulation Journal - June 21, 2021 Category: Cardiology Authors: Yousaku Okubo Takehito Tokuyama Sho Okamura Yoshihiro Ikeuchi Shunsuke Miyauchi Yukiko Nakano MYBEAT Trial Investigators Source Type: research
